Skip to content
Friday, June 27
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Sports
  • Press Release
The Prime Media

The Prime Media

Just another WordPress site

The Prime Media

The Prime Media

Just another WordPress site

  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Sports
  • Press Release
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Sports
  • Press Release
Trending Now
  • Unlocking Opportunities: Your Guide to Business Setup in Dubai
  • Ralla Bella Dancing Super Star – Season 7 All Set to Light Up Visakhapatnam by Pace Creators Dance Academy
  • From a Small Town in Assam to the Big 4: Vicky Baruah’s Incredible MBA Journey At Kaziranga University
  • Founders Under 40 Who Are Building the Next Big Thing
  • Inauguration of Electric Vehicles in TATA Steel
  • Silky Overseas Limited IPO To Open On 30th June, Sets Price Band At ₹153 to ₹161 Per Share
Home>>Press Release>>Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore
Press Release

Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore

August 23, 2023

Teestar by Avesthagen

Bangalore (Karnataka) [India], August 23: Teestar® botanical chewables by Avesthagen Limited, a product designed for sugar and weight management, specifically targeting pre-diabetic and diabetic healthcare. Teestar® is a scientifically formulated nutraceutical using all-natural plant-based ingredients. The product has gained recognition as a finalist for the NutraIngredients-Asia 2023 Award and will be showcased at the show at Marina Bay Sands in Singapore on September 26th 2023. 

With an emphasis on preventive care and general wellness, Avesthagen’s line of bioactive compounds aims to offer naturally occurring, clinically confirmed treatments for numerous disease-specific health issues like Diabetes and Cardiovascular Health. Teestar® chewables are developed to help manage blood sugar levels, particularly after meals, with reported reductions in postprandial blood glucose levels of up to 10 mg/dL. The product also aids in better insulin response.

Teestar® is formulated from an Indian medicinal plant that has traditionally been a part of the food matrix. The recommended dosage for Teestar® is to consume two chewables before breakfast and dinner daily for optimal results. 

Dr. Renuka Jain, President of Avesta Nordic Research Pvt. Ltd., explains that Teestar® forms a colloidal-type suspension in the stomach and intestines upon hydration. This leads to slower gastrointestinal transit and digestion of food, resulting in lesser glucose being absorbed from digested food and a prolonged feeling of satiety.

Teestar® is manufactured in a state-of-the-art production and R&D facility using an eco-friendly and safe extraction process that uses only ethanol and water. Using Avesthagen’s unique fingerprinting method, MetaGrid®, the product’s consistency in quality is maintained.

Event Showcase: Teestar® Botanical Chewables have been selected as a finalist and are scheduled to be showcased at the Nutra Ingredient Asia Show, which will take place at Marina Bay Sands in Singapore on September 26th, 2023. This event aims to highlight Avesthagen’s ‘Food for Medicine’ program, which is focused on the scientific validation of traditional medicine knowledge and natural plant ingredients leading to plant-based medicines for preventive healthcare and treatment of specific disease conditions.

Teestar® Botanical Chewables are promoted as a safe and potent calorie modulator that can assist in managing healthy body mass.

Teestar® is available in two flavors: Litchi and Tamarind, priced at Rs. 750/-. The websites www.avestagoodearthfoods.com, www.amazon.in, and www.1mg.com offer it for sale.

About Avesthagen: 

Avesthagen Limited is an international and diversified life sciences company that follows a systems-biology approach. The company is a pioneer in merging the fields of food, pharmaceuticals, and population genetics to create innovative products and therapies. Avesthagen’s focus lies in bringing its developed products and technologies to the market, with a particular emphasis on Nutrigenomics, Agriculture, and Precision Medicine. They utilize their proprietary Predictive, Preventive, and Personalized (“PPP”) healthcare platform to achieve these goals.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Related tags : PNN

Previous Post

BullSmart hosts its very first financial influencer meetup in Delhi NCR

Next Post

Preserving the Past: Exploring USA’s Historic Sites and Landmarks

Related Articles

Press Release

Rain and Revelry Mark the Opening of Saputara Megh Malhar Festival 2024

Press Release

Ravi Shastri’s Champion of Champions installation unveiled at “Alibag”

Press Release

8 Students Embarking on their International Academic Journey with Global Citizen Scholarship

Press Release

Defying Norms, Embracing Dreams: The Inspirational Journey of Shweta Anand

Press Release

BTS: Insights into the Minds of the Most Influential Generation

Recent Posts

  • Unlocking Opportunities: Your Guide to Business Setup in Dubai
  • Ralla Bella Dancing Super Star – Season 7 All Set to Light Up Visakhapatnam by Pace Creators Dance Academy
  • From a Small Town in Assam to the Big 4: Vicky Baruah’s Incredible MBA Journey At Kaziranga University
  • Founders Under 40 Who Are Building the Next Big Thing
  • Inauguration of Electric Vehicles in TATA Steel

Recent Comments

    © 2025 The Prime Media | WordPress Theme Ultra News
    • Business
    • Entertainment
    • National
    • Lifestyle
    • Education
    • Sports
    • Press Release